Fig 1.
Flowsheet of enrollment, randomization and screening results for VIA and VILI.
Table 1.
Baseline demographic and clinical characteristics of HIV-infected women randomized to cervical cancer screening with Visual Inspection with Acetic Acid (VIA) or Visual Inspection with Lugol's Iodine (VILI).
Table 2.
Clinical performance of VIA and VILI for diagnosis of CIN.
Table 3.
Clinical performance of VIA or VILI for detection of CIN2+, stratified by age, CD4+ count, and HAART use.